Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2025-12-17 @ 3:39 AM
Study NCT ID: NCT00040391
Protocol Section: NCT00040391
Start Identification Module Data
Brief Title: A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Official Title: A Phase II, Randomized, Open-label, Controlled, Dose-elevation, Multicenter Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer
Acronym: None
Organization: Celgene Corporation
Organization Class: INDUSTRY
Organization Study ID: 440E-ONC-0020-315
Start Status Module Data
Status Verified Date: 2016-11
Overall Status: None
Study First Submit Date: 2002-06-26
Study First Submit QC Date:
Last Update Submit Date: 2016-11-30
Status: TERMINATED
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Celgene Corporation
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Celgene Corporation
Start Oversight Module Data 5813
Description Module: 8467
Study Last Update Post Date Type(Status Module):
Attachment: Upload